Form 4 for ATLX Atlas Lithium Corp
Accepted 2022-06-17 00:00:00 ET · period of report 2017-06-30 · accession 0001493152-22-017133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-17 | 2021-02-12+ | ATLX | Noriega Roger | Dir | M - OptEx | $0.033 | +110.40M | 68.37M | New | +$3.65M |
| DM | 2022-06-17 | 2021-02-12+ | ATLX | Noriega Roger | Dir | M - OptEx | $0.0331 | -117.05M | 44.97M | -72% | -$3.87M |
| DM | 2022-06-17 | 2017-06-30+ | ATLX | Noriega Roger | Dir | A - Grant | — | +118.10M | 118.10M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 13,717,172 | $0.03 | 58,269,404 | D | — | — | (F10) Stock received in connection with reporting person's cashless exercise of stock options granted on 6/30/2019. Reflects 535,828 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 14,253,000 options. |
| 2 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 2,909,479 | $0.03 | 61,178,883 | D | — | — | (F11) Stock received in connection with reporting person's cashless exercise of stock options granted on 9/30/2019. Reflects 561,021 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 3,470,500 options. |
| 3 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 6,405,860 | $0.04 | 21,100,845 | D | — | — | (F7) Stock received in connection with reporting person's cashless exercise of stock options granted on 9/30/2018. Reflects 280,140 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 6,686,000 options. |
| 4 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 4,387,298 | $0.04 | 8,454,410 | D | — | — | (F5) Stock received in connection with reporting person's cashless exercise of stock options granted on 3/31/2018. Reflects 505,702 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 4,893,000 options. |
| 5 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 1,245,836 | $0.04 | 1,248,194 | D | — | — | (F1) This Report on Form 4 discloses previously unreported non-derivative security transactions effected by or on behalf of the reporting person since February 12, 2021. (F2) Stock received in connection with reporting person's cashless exercise of stock options granted on 9/30/2017. Reflects 352,764 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 1,598,600 options. (F3) The amount of securities beneficially owned by the reporting person prior to this transaction was 2,358 as a result of a reverse stock split effected by the Issuer on January 27, 2017. |
| 6 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 2,818,918 | $0.04 | 4,067,112 | D | — | — | (F4) Stock received in connection with reporting person's cashless exercise of stock options granted on 12/31/2017. Reflects 354,582 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 3,173,500 options. |
| 7 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 11,147,142 | $0.03 | 44,552,232 | D | — | — | (F9) Stock received in connection with reporting person's cashless exercise of stock options granted on 3/31/2019. Reflects 480,858 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 11,628,000 options. |
| 8 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 12,304,245 | $0.04 | 33,405,090 | D | — | — | (F8) Stock received in connection with reporting person's cashless exercise of stock options granted on 12/31/2018. Reflects 500,755 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 12,805,000 options. |
| 9 | Common | Common Stock, par value $.001 per share | 2021-02-12 | M | A | 6,240,575 | $0.04 | 14,694,985 | D | — | — | (F6) Stock received in connection with reporting person's cashless exercise of stock options granted on 6/30/2018. Reflects 448,425 shares withheld at the cashless exercise price of $0.0358 per share to fund the cashless exercise of 6,689,000 options. |
| 10 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 9,613,473 | $0.03 | 110,398,396 | D | — | — | (F16) Stock received in connection with reporting person's cashless exercise of stock options granted on 12/31/2020. Reflects 375,527 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 9,989,000 options. |
| 11 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 13,546,635 | $0.03 | 100,784,923 | D | — | — | (F15) Stock received in connection with reporting person's cashless exercise of stock options granted on 9/30/2020. Reflects 584,365 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 14,131,000 options. |
| 12 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 10,930,116 | $0.03 | 87,238,288 | D | — | — | (F14) Stock received in connection with reporting person's cashless exercise of stock options granted on 6/30/2020. Reflects 516,384 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 11,446,500 options. |
| 13 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 7,940,966 | $0.03 | 76,308,172 | D | — | — | (F13) Stock received in connection with reporting person's cashless exercise of stock options granted on 3/31/2020. Reflects 408,034 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 8,349,000 options. |
| 14 | Common | Common Stock, par value $.001 per share | 2021-03-02 | M | A | 7,188,323 | $0.03 | 68,367,206 | D | — | — | (F12) Stock received in connection with reporting person's cashless exercise of stock options granted on 12/31/2019. Reflects 745,677 shares withheld at the cashless exercise price of $0.0266 per share to fund the cashless exercise of 7,934,000 options. |
| 15 | Derivative | Common Stock Options | 2021-03-02 | M | D | 8,349,000 | $0.03 | 36,621,500 | D | — · — to 2025-03-31 | 8,349,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 16 | Derivative | Common Stock Options | 2021-03-02 | M | D | 11,446,500 | $0.03 | 25,175,000 | D | — · — to 2025-06-30 | 11,446,500 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 17 | Derivative | Common Stock Options | 2021-03-02 | M | D | 14,131,000 | $0.03 | 11,044,000 | D | — · — to 2025-09-30 | 14,131,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 18 | Derivative | Common Stock Options | 2021-03-02 | M | D | 9,989,000 | $0.03 | 1,055,000 | D | — · — to 2025-12-31 | 9,989,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 19 | Derivative | Common Stock Options | 2017-06-30 | A | A | 1,055,000 | — | 1,055,000 | D | $0.02 · 2017-06-30 to 2022-06-30 | 1,055,000 Common Stock | (F17) This Report on Form 4 discloses previously unreported derivative security transactions effected by or on behalf of the reporting person since June 30, 2017. (F18) Quarterly award of Stock Options for services as a director. |
| 20 | Derivative | Common Stock Options | 2017-09-30 | A | A | 1,598,600 | — | 2,653,600 | D | $0.01 · 2017-09-30 to 2022-09-30 | 1,598,600 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 21 | Derivative | Common Stock Options | 2017-12-31 | A | A | 3,173,500 | — | 5,827,100 | D | $0.00 · 2017-12-31 to 2022-12-31 | 3,173,500 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 22 | Derivative | Common Stock Options | 2018-03-31 | A | A | 4,893,000 | — | 10,720,100 | D | $0.00 · 2018-03-31 to 2023-03-31 | 4,893,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 23 | Derivative | Common Stock Options | 2018-06-30 | A | A | 6,689,000 | — | 17,409,100 | D | $0.00 · 2018-06-30 to 2023-06-30 | 6,689,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 24 | Derivative | Common Stock Options | 2018-09-30 | A | A | 6,686,000 | — | 24,095,100 | D | $0.00 · 2018-09-30 to 2023-09-30 | 6,686,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 25 | Derivative | Common Stock Options | 2018-12-31 | A | A | 12,805,000 | — | 36,900,100 | D | $0.00 · 2018-12-31 to 2023-12-31 | 12,805,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 26 | Derivative | Common Stock Options | 2019-03-31 | A | A | 11,628,000 | — | 48,528,100 | D | $0.00 · 2019-03-31 to 2024-03-31 | 11,628,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 27 | Derivative | Common Stock Options | 2019-06-30 | A | A | 14,253,000 | — | 62,781,100 | D | $0.00 · 2019-06-30 to 2024-06-30 | 14,253,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 28 | Derivative | Common Stock Options | 2019-09-30 | A | A | 3,470,500 | — | 66,251,600 | D | $0.00 · 2019-09-30 to 2024-09-30 | 3,470,500 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 29 | Derivative | Common Stock Options | 2019-12-31 | A | A | 7,934,000 | — | 74,185,600 | D | $0.00 · 2019-12-31 to 2024-12-31 | 7,934,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 30 | Derivative | Common Stock Options | 2020-03-31 | A | A | 8,349,000 | — | 82,534,600 | D | $0.00 · 2020-03-31 to 2025-03-31 | 8,349,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 31 | Derivative | Common Stock Options | 2020-06-30 | A | A | 11,446,500 | — | 93,981,100 | D | $0.00 · 2020-06-30 to 2025-06-30 | 11,446,500 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 32 | Derivative | Common Stock Options | 2020-09-30 | A | A | 14,131,000 | — | 108,112,100 | D | $0.00 · 2020-09-30 to 2025-09-30 | 14,131,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 33 | Derivative | Common Stock Options | 2020-12-31 | A | A | 9,989,000 | — | 118,101,100 | D | $0.00 · 2020-12-31 to 2025-12-31 | 9,989,000 Common Stock | (F18) Quarterly award of Stock Options for services as a director. |
| 34 | Derivative | Common Stock Options | 2021-02-12 | M | D | 1,598,600 | $0.04 | 116,502,500 | D | — · — to 2022-09-30 | 1,598,600 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 35 | Derivative | Common Stock Options | 2021-02-12 | M | D | 3,173,500 | $0.04 | 113,329,000 | D | — · — to 2022-12-31 | 3,173,500 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 36 | Derivative | Common Stock Options | 2021-02-12 | M | D | 4,893,000 | $0.04 | 108,436,000 | D | — · — to 2023-03-31 | 4,893,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 37 | Derivative | Common Stock Options | 2021-02-12 | M | D | 6,689,000 | $0.04 | 101,747,000 | D | — · — to 2023-06-30 | 6,689,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 38 | Derivative | Common Stock Options | 2021-02-12 | M | D | 6,686,000 | $0.04 | 95,061,000 | D | — · — to 2023-09-30 | 6,686,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 39 | Derivative | Common Stock Options | 2021-02-12 | M | D | 12,805,000 | $0.04 | 82,256,000 | D | — · — to 2023-12-31 | 12,805,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 40 | Derivative | Common Stock Options | 2021-03-02 | M | D | 11,628,000 | $0.03 | 70,628,000 | D | — · — to 2024-03-31 | 11,628,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 41 | Derivative | Common Stock Options | 2021-03-02 | M | D | 14,253,000 | $0.03 | 56,375,000 | D | — · — to 2024-06-30 | 14,253,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 42 | Derivative | Common Stock Options | 2021-03-02 | M | D | 3,470,500 | $0.03 | 52,904,500 | D | — · — to 2024-09-30 | 3,470,500 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |
| 43 | Derivative | Common Stock Options | 2021-03-02 | M | D | 7,934,000 | $0.03 | 44,970,500 | D | — · — to 2024-12-31 | 7,934,000 Common Stock | (F19) Stock Options exercised at the exercise price disclosed on Table I to this Report on Form 4 on the corresponding transaction date. (F20) The Stock Options had fully vested upon issuance and were fully exercised as shown on Table I above. |